Home Applications 215192 Application 215192
Type NDA
Sponsor AKEBIA Application Products# Product, Drug, Ingredient table Product Drug Ingredient Form Strength Reference drug Reference standard 001 VAFSEO VADADUSTAT TABLET;ORAL 150MG Yes No 002 VAFSEO VADADUSTAT TABLET;ORAL 300MG Yes No 003 VAFSEO VADADUSTAT TABLET;ORAL 450MG Yes Yes
Source provenance: Browse the complete Orange Book source catalog · source snapshot 44 .
Orange Book products# Current product rows page 1 of 1 · 3 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N215192-001 VAFSEO VADADUSTAT 150MG TABLET / ORAL RLD 2024-03-27 N215192-002 VAFSEO VADADUSTAT 300MG TABLET / ORAL RLD 2024-03-27 N215192-003 VAFSEO VADADUSTAT 450MG TABLET / ORAL RLD 2024-03-27
Orange Book patents# Current patent rows page 1 of 1 · 42 matching rows.
Application-product, Patent, Expiration table Application-product Patent Expiration Use code Coverage / status Submission date N215192-001 8598210 2027-06-26 Drug substance, Drug product 2024-04-10 N215192-001 8940773 2027-06-26 U-3876 2024-04-10 N215192-001 RE47437 2027-06-26 Drug substance, Drug product 2024-04-10 N215192-001 8343952 2027-08-14 Drug substance, Drug product 2024-04-10 N215192-001 7811595 2028-03-13 Drug substance, Drug product 2024-04-10 N215192-001 8323671 2028-04-03 U-3876 2024-04-10 N215192-001 12569474 2034-06-04 U-3876 2026-03-25 N215192-001 11857543 2034-06-09 U-3876 2024-04-10 N215192-001 10149842 2034-11-14 Drug substance, Drug product 2024-04-10 N215192-001 11065237 2034-11-14 U-3876 Drug substance, Drug product 2024-04-10 N215192-001 9701636 2034-11-14 Drug substance, Drug product 2024-04-10 N215192-001 9987262 2034-11-14 U-3876 2024-04-10 N215192-001 11324734 2036-03-31 Drug product 2024-04-10 N215192-001 11844756 2036-03-31 U-3876 2024-04-10 N215192-002 8598210 2027-06-26 Drug substance, Drug product 2024-04-10 N215192-002 8940773 2027-06-26 U-3876 2024-04-10 N215192-002 RE47437 2027-06-26 Drug substance, Drug product 2024-04-10 N215192-002 8343952 2027-08-14 Drug substance, Drug product 2024-04-10 N215192-002 7811595 2028-03-13 Drug substance, Drug product 2024-04-10 N215192-002 8323671 2028-04-03 U-3876 2024-04-10 N215192-002 12569474 2034-06-04 U-3876 2026-03-25 N215192-002 11857543 2034-06-09 U-3876 2024-04-10 N215192-002 10149842 2034-11-14 Drug substance, Drug product 2024-04-10 N215192-002 11065237 2034-11-14 U-3876 Drug substance, Drug product 2024-04-10 N215192-002 9701636 2034-11-14 Drug substance, Drug product 2024-04-10 N215192-002 9987262 2034-11-14 U-3876 2024-04-10 N215192-002 11324734 2036-03-31 Drug product 2024-04-10 N215192-002 11844756 2036-03-31 U-3876 2024-04-10 N215192-003 8598210 2027-06-26 Drug substance, Drug product 2024-04-10 N215192-003 8940773 2027-06-26 U-3876 2024-04-10 N215192-003 RE47437 2027-06-26 Drug substance, Drug product 2024-04-10 N215192-003 8343952 2027-08-14 Drug substance, Drug product 2024-04-10 N215192-003 7811595 2028-03-13 Drug substance, Drug product 2024-04-10 N215192-003 8323671 2028-04-03 U-3876 2024-04-10 N215192-003 12569474 2034-06-04 U-3876 2026-03-25 N215192-003 11857543 2034-06-09 U-3876 2024-04-10 N215192-003 10149842 2034-11-14 Drug substance, Drug product 2024-04-10 N215192-003 11065237 2034-11-14 U-3876 Drug substance, Drug product 2024-04-10 N215192-003 9701636 2034-11-14 Drug substance, Drug product 2024-04-10 N215192-003 9987262 2034-11-14 U-3876 2024-04-10 N215192-003 11324734 2036-03-31 Drug product 2024-04-10 N215192-003 11844756 2036-03-31 U-3876 2024-04-10
Orange Book exclusivity# Current exclusivity rows page 1 of 1 · 3 matching rows.
Application-product, Exclusivity code, Expiration table Application-product Exclusivity code Expiration N215192-001 NCE 2029-03-27 N215192-002 NCE 2029-03-27 N215192-003 NCE 2029-03-27
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 2 · 54 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-10-15 13:18:30 2026-09 N215192-001 VAFSEO 150MG TABLET / ORAL RLD 2024-03-27 c2088c7a36db…2026-10-15 13:18:30 2026-09 N215192-002 VAFSEO 300MG TABLET / ORAL RLD 2024-03-27 c2088c7a36db…2026-10-15 13:18:30 2026-09 N215192-003 VAFSEO 450MG TABLET / ORAL RLD 2024-03-27 c2088c7a36db…2026-09-14 22:38:34 2026-08 N215192-001 VAFSEO 150MG TABLET / ORAL RLD 2024-03-27 84e616aacf4f…2026-09-14 22:38:34 2026-08 N215192-002 VAFSEO 300MG TABLET / ORAL RLD 2024-03-27 84e616aacf4f…2026-09-14 22:38:34 2026-08 N215192-003 VAFSEO 450MG TABLET / ORAL RLD 2024-03-27 84e616aacf4f…2026-08-18 06:07:40 2026-07 N215192-001 VAFSEO 150MG TABLET / ORAL RLD 2024-03-27 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N215192-002 VAFSEO 300MG TABLET / ORAL RLD 2024-03-27 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N215192-003 VAFSEO 450MG TABLET / ORAL RLD, RS 2024-03-27 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N215192-001 VAFSEO 150MG TABLET / ORAL RLD 2024-03-27 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N215192-002 VAFSEO 300MG TABLET / ORAL RLD 2024-03-27 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N215192-003 VAFSEO 450MG TABLET / ORAL RLD, RS 2024-03-27 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N215192-001 VAFSEO 150MG TABLET / ORAL RLD 2024-03-27 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N215192-002 VAFSEO 300MG TABLET / ORAL RLD 2024-03-27 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N215192-003 VAFSEO 450MG TABLET / ORAL RLD, RS 2024-03-27 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N215192-001 VAFSEO 150MG TABLET / ORAL RLD 2024-03-27 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N215192-002 VAFSEO 300MG TABLET / ORAL RLD 2024-03-27 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N215192-003 VAFSEO 450MG TABLET / ORAL RLD, RS 2024-03-27 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N215192-001 VAFSEO 150MG TABLET / ORAL RLD 2024-03-27 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N215192-002 VAFSEO 300MG TABLET / ORAL RLD 2024-03-27 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N215192-003 VAFSEO 450MG TABLET / ORAL RLD, RS 2024-03-27 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N215192-001 VAFSEO 150MG TABLET / ORAL RLD 2024-03-27 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N215192-002 VAFSEO 300MG TABLET / ORAL RLD 2024-03-27 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N215192-003 VAFSEO 450MG TABLET / ORAL RLD, RS 2024-03-27 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N215192-001 VAFSEO 150MG TABLET / ORAL RLD 2024-03-27 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N215192-002 VAFSEO 300MG TABLET / ORAL RLD 2024-03-27 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N215192-003 VAFSEO 450MG TABLET / ORAL RLD, RS 2024-03-27 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N215192-001 VAFSEO 150MG TABLET / ORAL RLD 2024-03-27 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N215192-002 VAFSEO 300MG TABLET / ORAL RLD 2024-03-27 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N215192-003 VAFSEO 450MG TABLET / ORAL RLD, RS 2024-03-27 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N215192-001 VAFSEO 150MG TABLET / ORAL RLD 2024-03-27 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N215192-002 VAFSEO 300MG TABLET / ORAL RLD 2024-03-27 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N215192-003 VAFSEO 450MG TABLET / ORAL RLD, RS 2024-03-27 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N215192-001 VAFSEO 150MG TABLET / ORAL RLD 2024-03-27 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N215192-002 VAFSEO 300MG TABLET / ORAL RLD 2024-03-27 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N215192-003 VAFSEO 450MG TABLET / ORAL RLD, RS 2024-03-27 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N215192-001 VAFSEO 150MG TABLET / ORAL RLD 2024-03-27 d06236e962d9…2024-10-29 15:01 UTC 2024-10 N215192-002 VAFSEO 300MG TABLET / ORAL RLD 2024-03-27 d06236e962d9…2024-10-29 15:01 UTC 2024-10 N215192-003 VAFSEO 450MG TABLET / ORAL RLD, RS 2024-03-27 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N215192-001 VAFSEO 150MG TABLET / ORAL RLD 2024-03-27 79d66fd596c7…
Observed Orange Book patent history# Patent history page 1 of 18 · 714 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Patent Expiration Use code Coverage / status Submission date Source SHA-256 2026-10-15 13:18:30 2026-09 N215192-001 8598210 2027-06-26 Drug substance, Drug product 2024-04-10 c2088c7a36db…2026-10-15 13:18:30 2026-09 N215192-001 8940773 2027-06-26 U-3876 2024-04-10 c2088c7a36db…2026-10-15 13:18:30 2026-09 N215192-001 RE47437 2027-06-26 Drug substance, Drug product 2024-04-10 c2088c7a36db…2026-10-15 13:18:30 2026-09 N215192-001 8343952 2027-08-14 Drug substance, Drug product 2024-04-10 c2088c7a36db…2026-10-15 13:18:30 2026-09 N215192-001 7811595 2028-03-13 Drug substance, Drug product 2024-04-10 c2088c7a36db…2026-10-15 13:18:30 2026-09 N215192-001 8323671 2028-04-03 U-3876 2024-04-10 c2088c7a36db…2026-10-15 13:18:30 2026-09 N215192-001 12569474 2034-06-04 U-3876 2026-03-25 c2088c7a36db…2026-10-15 13:18:30 2026-09 N215192-001 11857543 2034-06-09 U-3876 2024-04-10 c2088c7a36db…2026-10-15 13:18:30 2026-09 N215192-001 10149842 2034-11-14 Drug substance, Drug product 2024-04-10 c2088c7a36db…2026-10-15 13:18:30 2026-09 N215192-001 11065237 2034-11-14 U-3876 Drug substance, Drug product 2024-04-10 c2088c7a36db…2026-10-15 13:18:30 2026-09 N215192-001 9701636 2034-11-14 Drug substance, Drug product 2024-04-10 c2088c7a36db…2026-10-15 13:18:30 2026-09 N215192-001 9987262 2034-11-14 U-3876 2024-04-10 c2088c7a36db…2026-10-15 13:18:30 2026-09 N215192-001 11324734 2036-03-31 Drug product 2024-04-10 c2088c7a36db…2026-10-15 13:18:30 2026-09 N215192-001 11844756 2036-03-31 U-3876 2024-04-10 c2088c7a36db…2026-10-15 13:18:30 2026-09 N215192-002 8598210 2027-06-26 Drug substance, Drug product 2024-04-10 c2088c7a36db…2026-10-15 13:18:30 2026-09 N215192-002 8940773 2027-06-26 U-3876 2024-04-10 c2088c7a36db…2026-10-15 13:18:30 2026-09 N215192-002 RE47437 2027-06-26 Drug substance, Drug product 2024-04-10 c2088c7a36db…2026-10-15 13:18:30 2026-09 N215192-002 8343952 2027-08-14 Drug substance, Drug product 2024-04-10 c2088c7a36db…2026-10-15 13:18:30 2026-09 N215192-002 7811595 2028-03-13 Drug substance, Drug product 2024-04-10 c2088c7a36db…2026-10-15 13:18:30 2026-09 N215192-002 8323671 2028-04-03 U-3876 2024-04-10 c2088c7a36db…2026-10-15 13:18:30 2026-09 N215192-002 12569474 2034-06-04 U-3876 2026-03-25 c2088c7a36db…2026-10-15 13:18:30 2026-09 N215192-002 11857543 2034-06-09 U-3876 2024-04-10 c2088c7a36db…2026-10-15 13:18:30 2026-09 N215192-002 10149842 2034-11-14 Drug substance, Drug product 2024-04-10 c2088c7a36db…2026-10-15 13:18:30 2026-09 N215192-002 11065237 2034-11-14 U-3876 Drug substance, Drug product 2024-04-10 c2088c7a36db…2026-10-15 13:18:30 2026-09 N215192-002 9701636 2034-11-14 Drug substance, Drug product 2024-04-10 c2088c7a36db…2026-10-15 13:18:30 2026-09 N215192-002 9987262 2034-11-14 U-3876 2024-04-10 c2088c7a36db…2026-10-15 13:18:30 2026-09 N215192-002 11324734 2036-03-31 Drug product 2024-04-10 c2088c7a36db…2026-10-15 13:18:30 2026-09 N215192-002 11844756 2036-03-31 U-3876 2024-04-10 c2088c7a36db…2026-10-15 13:18:30 2026-09 N215192-003 8598210 2027-06-26 Drug substance, Drug product 2024-04-10 c2088c7a36db…2026-10-15 13:18:30 2026-09 N215192-003 8940773 2027-06-26 U-3876 2024-04-10 c2088c7a36db…2026-10-15 13:18:30 2026-09 N215192-003 RE47437 2027-06-26 Drug substance, Drug product 2024-04-10 c2088c7a36db…2026-10-15 13:18:30 2026-09 N215192-003 8343952 2027-08-14 Drug substance, Drug product 2024-04-10 c2088c7a36db…2026-10-15 13:18:30 2026-09 N215192-003 7811595 2028-03-13 Drug substance, Drug product 2024-04-10 c2088c7a36db…2026-10-15 13:18:30 2026-09 N215192-003 8323671 2028-04-03 U-3876 2024-04-10 c2088c7a36db…2026-10-15 13:18:30 2026-09 N215192-003 12569474 2034-06-04 U-3876 2026-03-25 c2088c7a36db…2026-10-15 13:18:30 2026-09 N215192-003 11857543 2034-06-09 U-3876 2024-04-10 c2088c7a36db…2026-10-15 13:18:30 2026-09 N215192-003 10149842 2034-11-14 Drug substance, Drug product 2024-04-10 c2088c7a36db…2026-10-15 13:18:30 2026-09 N215192-003 11065237 2034-11-14 U-3876 Drug substance, Drug product 2024-04-10 c2088c7a36db…2026-10-15 13:18:30 2026-09 N215192-003 9701636 2034-11-14 Drug substance, Drug product 2024-04-10 c2088c7a36db…2026-10-15 13:18:30 2026-09 N215192-003 9987262 2034-11-14 U-3876 2024-04-10 c2088c7a36db…
Observed Orange Book exclusivity history# Exclusivity history page 1 of 2 · 54 observed states.
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Brand, Generic, Manufacturer table Brand Generic Manufacturer SPL set ID Effective date Available safety fields Join VAFSEO VADADUSTAT Akebia Therapeutics, Inc. ac9da724-5a62-4ab6-a89c-376a25f6195b 2026-03-30 Boxed warning, Warnings, Adverse reactions Exact identifier application applno (NDA): 215192 application number: NDA215192
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
Documents# Document, Submission type, Date table Document Submission type Date 85634 SUPPL 2026-04-02 85633 SUPPL 2026-04-02 78206 ORIG 2024-04-23 78007 ORIG 2024-03-29 78006 ORIG 2024-03-29 78003 ORIG 2024-03-28